BRIEF-Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO

Reuters01-17

Jan 17 (Reuters) - NeuBase Therapeutics Inc :

* NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED EMPLOYMENT OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF COMPANY, WITHOUT CAUSE

* NEUBASE THERAPEUTICS- APPOINTED TODD P. BRANNING, WHO HAS SERVED AS COMPANY'S CFO SINCE JANUARY 2022, AS INTERIM CEO

* NEUBASE THERAPEUTICS INC: DIETRICH A. STEPHAN IS EXPECTED TO CONTINUE TO SERVE ON BOARD

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2404033695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-01-17 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2404033695","market":"us","top_or_hot":-1,"title":"BRIEF-Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO","media":"Reuters","content":"<html><body><p>Jan 17 (Reuters) - NeuBase Therapeutics Inc   :</p><p>   * NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED EMPLOYMENT OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF COMPANY, WITHOUT CAUSE</p><p>   * NEUBASE THERAPEUTICS-  APPOINTED TODD P. BRANNING, WHO HAS SERVED AS COMPANY'S CFO SINCE JANUARY 2022, AS INTERIM CEO</p><p>   * NEUBASE THERAPEUTICS INC: DIETRICH A. STEPHAN IS EXPECTED TO CONTINUE TO SERVE ON BOARD</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-17 19:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jan 17 (Reuters) - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED EMPLOYMENT OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF COMPANY, WITHOUT CAUSE ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NBSE","symbol_name":"NeuBase Therapeutics Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2404033695","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2404033695","pubTimestamp":1705490512,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Jan 17  - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED EMPLOYMENT OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF COMPANY, WITHOUT CAUSE   * NEUBASE THERAPEUTICS-  APPOINTED TODD P. BRANNING, WHO HAS SERVED AS COMPANY'S CFO SINCE JANUARY 2022, AS INTERIM CEO   * NEUBASE THERAPEUTICS INC: DIETRICH A. STEPHAN IS EXPECTED TO CONTINUE TO SERVE ON BOARDFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NBSE":"NeuBase Therapeutics Inc.","BK4139":"生物科技"},"translate_title":"简报——Neubase Therapeutics董事会终止聘用Dietrich Stephan担任首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBSE":0.9},"content_text":"Jan 17 (Reuters) - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS INC: ON JAN 12, BOARD TERMINATED EMPLOYMENT OF DIETRICH A. STEPHAN, PH.D. AS CHIEF EXECUTIVE OFFICER OF COMPANY, WITHOUT CAUSE   * NEUBASE THERAPEUTICS-  APPOINTED TODD P. BRANNING, WHO HAS SERVED AS COMPANY'S CFO SINCE JANUARY 2022, AS INTERIM CEO   * NEUBASE THERAPEUTICS INC: DIETRICH A. STEPHAN IS EXPECTED TO CONTINUE TO SERVE ON BOARDFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2404033695"}